21 May 2024
21 May 2024
GSK hopes that it will receive a regulatory decision on depemokimab in 2025.
Data shows the industry is turning towards decentralization to study the effects of drugs in older populations, but how can Decentralized Clinical Trials (DCTs) be implemented in a suitable, age-appropriate way?
The company’s monoclonal antibody met primary and secondary endpoints as a maintenance therapy for ulcerative colitis in a Phase III trial.
The combination treatment was found to be well tolerated without demonstrating any dose-limiting toxicity.
The study will assess the tolerability, safety, food effect, and pharmacokinetics of RLA-23174.
KOLs have suggested the development of non-injectable fertility medications represents an unmet need.
The trial aims to assess the safety and tolerability of GIGA-564 in patients with metastatic or locally advanced solid tumours.
Intravenous acetaminophen showed potential in reducing the risk of organ injury and acute respiratory distress syndrome.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
